Вы находитесь на странице: 1из 2

“一带一路”专馆和外国团组展区“Belt & Road” Area and International Pavilions 表格提交 Forms

表 10
Form 10
项目融资路演会报名表
Application for Project Financing Roadshow

截止日期:2018 年 10 月 28 日
有需求才提交资料
Deadline: October 28, 2018
Optional to submit

参会单位 CIMAB SA (加盖公章)


Name of Company Seal/Signature
Organization/
Company:
参会身份
□投资方 Investor □项目方 Project owner
Participate as
是否参展商
所属展区 展位号
Are you an
(参展商填写) (参展商填写)
exhibitor?
Exhibition Area Booth No.
(Yes/No)
参会人数
参会人
Number of
Attendee
Attendee
手 机 传 真
Mobile Fax
联系电话
E-mail
Contact Number
网 址 邮 编
Website Postal Code
□项目路演 Business Roadshow
参会计划 □参会 Attend Meeting
Plan □会场广告 On-site Advertisement
□寻找合作项目 Pitching

以下为项目方填写 The following information should be filled out by the project owner.

Pharmaceutical formulation (Neuroepo) of selected glycoforms of recombinant


项目名称
human erythropoietin with therapeutic potential for several brain
Project Name
inflammatory diseases, like stroke and neurodegenerative diseases.
所属行业
Biotech and Pharma Industry
Industry
“一带一路”专馆和外国团组展区“Belt & Road” Area and International Pavilions 表格提交 Forms

Pharmaceutical formulation (Neuroepo) of selected glycoforms of


recombinant human erythropoietin with therapeutic potential for several
brain inflammatory diseases, like stroke and neurodegenerative diseases.

Target: Neurodegenerative diseases


Mechanism of Action: Anti-excitotoxic, mitoprotective, antioxidant,
anti-apoptotic,
参会
Intellectual Property: Nasal formulation (Patent WO2007009404A1)
项目
 GMP production process at industrial scale has been set up.
简介  Phase II/III clinical trial in Ataxia Spinocerebellar type 2 has been
Brief Introduction completed with positive results and demonstration of effects as
of the Project neuroprotective. Registration is under evaluation for Cuban
Regulatory Authority.
 Phase II/III clinical trial in Stroke is ongoing.
 Physician led Phase I in Parkinson shows safety. Phase II/III clinical
trial in Parkinson’s disease is ongoing.
 Phase II/III clinical trial in Alzheimer’s disease is ongoing.

融资金额 Joint Venture Agreem et


出让股份
Financing  30,000 000 USD to be negotiated from
Shares to Transfer
Amount 50%/50%

请于 10 月 28 日前将报名表发送到 278243299@qq.com
联系人:罗先生 手 机:13537738577
电 话:0755-82358211 传 真:0755-25831606
网 址:www.szci.org www.chtf.com
地 址:深圳市笋岗东路 12 号中民时代广场 B 座 35 楼深圳市投资商会

Please send this application form to 278243299@qq.com before Oct. 28, 2018
Contact Person:Mr. Luo Mobile:13537738577
Office Number:+86-755-82358211 Fax:+86-755-25831606
Website:www.szci.org www.chtf.com
Address : Shenzhen Investment Chamber of Commerce, 35 floor, Tower B, Zhongmin Times Square, No.12
Sungang East Road, Shenzhen

Вам также может понравиться